Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2020-002285-14-NL
EUCTR2020-002285-14-NL
Active, not recruiting
Phase 1

Effectiveness of corticosteroid injection in treatment of trigger fingers: a double blinded randomized clinical trial - Lokal Steroid in triggerfingers

JEROEN BOSCH HOSPITA0 sites300 target enrollmentJune 9, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTrigger finger (stenosing tenosynovitis) is one of the most common conditions seen by hand surgeons,Although not a severe disease, trigger fingers give disabling complaints in performance of work and ADL activities. The triggering is caused by a size mismatch between the first annular pulley (A1) and the corresponding flexor tendon sheath, but the precise etiology still remains unclear.2-4 Most often, trigger fingers do not resolve spontaneously and need some kind of treatment.Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Drugs-Depo-Medrol: ATC code H02AB04 – Methylprednisolone: RVG code 00605Kenacort-10 H02AB08 - Triamcinolone acetonide RVG code 01591Kenacort-40 H02AB08 - Triamcinolone acetonide RVG code 05341

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Trigger finger (stenosing tenosynovitis) is one of the most common conditions seen by hand surgeons,Although not a severe disease, trigger fingers give disabling complaints in performance of work and ADL activities. The triggering is caused by a size mismatch between the first annular pulley (A1) and the corresponding flexor tendon sheath, but the precise etiology still remains unclear.2-4 Most often, trigger fingers do not resolve spontaneously and need some kind of treatment.
Sponsor
JEROEN BOSCH HOSPITA
Enrollment
300
Status
Active, not recruiting
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 9, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
JEROEN BOSCH HOSPITA

Eligibility Criteria

Inclusion Criteria

  • •order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • •\-One or more trigger fingers
  • •\-Grade 1\-3 trigger finger (according to classification by Quinnell)
  • •\-Participation is voluntary and with informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 180
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 120

Exclusion Criteria

  • •A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • •\-Aged \<18
  • •\-Congenital trigger finger
  • •\-Mentally disabled persons
  • •\-Grade 4 trigger finger (according to classification by Quinell)
  • •\-Allergy for corticosteroids
  • •\-Previous surgical release for triggering
  • •\-Previous injection therapy
  • •\-History of surgical intervention in the same digit

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
ocal steroids for triggerfingers
NL-OMON26599Jeroen Bosch Hospital,300
Completed
Phase 4
Effectiveness of corticosteroid injection in treatment of trigger fingers: a double blinded randomized clinical trialtenosynovitistriggerfinger10043237
NL-OMON54114Jeroen Bosch Ziekenhuis300
Active, not recruiting
Phase 4
Effectiveness of corticosteroids in controlling complications after bichectomy surgery
ISRCTN15802039Austral University of Chile50
Completed
Not Applicable
Effect of corticosteroid injection in treatment of carpal tunnel syndrome
IRCT2017010831833N1Isfahan University of Medical Science60
Completed
Not Applicable
Corticosteroid in brucellosisBrucellosis.Brucellosis, unspecified
IRCT201106296922N1Zanjan University of Medical Sciences47